Ayr Wellness: New Name, Same Game
- Ayr Wellness is poised for substantial growth through 2022.
- The small MSO will quickly rival the size of global cannabis stocks with market valuations in excess of $10 billion.
- The stock trades at only 7.6x EV/2022 EBITDA target of $325 million.
- This idea was discussed in more depth with members of my private investing community, Out Fox The Street. Learn More »
In a matter of months, Ayr Strategies (OTCQX:AYRWF) made a transformative deal in Florida and changed their name to Ayr Wellness. The U.S. multi-state operator ("MSO") now forecasts massive revenue and adjusted EBITDA targets in 2022 making the company a major player in the cannabis world. My investment thesis remains very bullish on the stock even after a 60% gain since the last article less than three months ago.
Read the full article on Seeking Alpha.
Disclosure: No position mentioned. Please read the disclaimer page for more details.